Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03702322 · ClinicalTrials.gov registry record · NA
Improving Voice Production for Adults With Age-related Dysphonia
A NA study of Presbylarynx and Age-Related Dysphonia, sponsored by University of Arizona.
- Active
- Registry status
- NA
- Development phase
- 220
- Enrollment target
- 2
- Study locations
NCT03702322: Active NA study of Presbylarynx and Age-Related Dysphonia, sponsored by University of Arizona.
NCT03702322 is a NA study of Presbylarynx and Age-Related Dysphonia that is active but no longer recruiting, run by University of Arizona. The registered enrollment target is 220 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03702322, a NA study of Presbylarynx and Age-Related Dysphonia, is active but no longer recruiting, sponsored by University of Arizona.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 220 participants
- Enrollment target
- 2
- Study locations
Study Summary
The objectives for this research are to determine the mechanisms by which specific therapy tasks improve voice in age-related dysphonia, and the conditions that limit the extent of improvement. The central hypothesis is that targeted therapy tasks will improve voice, and that severity will determine the extent of improvement.
Conditions Studied
Interventions
- BEHAVIORAL Voice therapy: respiratory
- BEHAVIORAL Voice therapy: glottal closure
- BEHAVIORAL Voice therapy: loud
- BEHAVIORAL Voice therapy: Semiocclusion
Study Locations (2)
Arizona
- Mayo Clinic - Scottsdale
- University of Arizona - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2026-12-30 |
| Phase | NA |
What the registry record for NCT03702322 still lists
NCT03702322 is an interventional study that assigns participants to a tested intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).
The record links to 2 conditions, with Presbylarynx appearing as the primary indexed condition, and to 4 interventions - of which Voice therapy: respiratory is the first listed.
NCT03702322 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT03702322 about?
NCT03702322 is a clinical study titled "Improving Voice Production for Adults With Age-related Dysphonia". The objectives for this research are to determine the mechanisms by which specific therapy tasks improve voice in age-related dysphonia, and the conditions that limit the extent of improvement. The central hypothesis is that targeted therapy tasks will improve voice, and that severity will determine...
What is the current status of trial NCT03702322?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 220 participants. The study started on 2019-04-01. Estimated completion is 2026-12-30.
What conditions does trial NCT03702322 study?
This clinical trial studies the following conditions: Presbylarynx, Age-Related Dysphonia.
What interventions are being tested in trial NCT03702322?
The interventions under investigation include: Voice therapy: respiratory (BEHAVIORAL), Voice therapy: glottal closure (BEHAVIORAL), Voice therapy: loud (BEHAVIORAL), Voice therapy: Semiocclusion (BEHAVIORAL).
Who is sponsoring clinical trial NCT03702322?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03702322 being conducted?
This trial has 2 study locations across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Presbylarynx
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03702322's enrollment target sits among peer trials
220 481st of 2000 higher than 1,516 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00920972 · 220 participants · Phase 1
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- NCT01851642 · 220 participants
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- NCT02582021 · 220 participants
WISE CVD - Continuation (WISE HFpEF)
- NCT04067830 · 220 participants · Phase 2
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI